CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan

BACKGROUND: The effectiveness of autologous haematopoietic stem cell transplantation (auto-HSCT) in treating severe systemic sclerosis (SSc) is established; however, the necessity of purified CD34+ cell grafts and the appropriate conditioning regimen remain unclear. This study aimed to compare the e...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Arthritis Res Ther
Main Authors: Ayano, Masahiro, Tsukamoto, Hiroshi, Mitoma, Hiroki, Kimoto, Yasutaka, Akahoshi, Mitsuteru, Arinobu, Yojiro, Miyamoto, Toshihiro, Horiuchi, Takahiko, Niiro, Hiroaki, Nagafuji, Koji, Harada, Mine, Akashi, Koichi
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6341635/
https://ncbi.nlm.nih.gov/pubmed/30670057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-1823-0
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki